Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (62) 62
male (48) 48
female (44) 44
index medicus (37) 37
middle aged (34) 34
adult (32) 32
aged (26) 26
endocrinology & metabolism (24) 24
cancer (19) 19
oncology (18) 18
adrenal cortex neoplasms - drug therapy (12) 12
aged, 80 and over (11) 11
medicine, general & internal (11) 11
mortality (11) 11
prognosis (11) 11
mitotane - therapeutic use (10) 10
risk (10) 10
therapy (10) 10
adolescent (9) 9
internal medicine (9) 9
management (9) 9
research (9) 9
risk factors (9) 9
survival (9) 9
adrenocortical carcinoma (8) 8
analysis (8) 8
child (8) 8
diabetes (8) 8
netherlands - epidemiology (8) 8
retrospective studies (8) 8
survival analysis (8) 8
young adult (8) 8
adrenal cortex neoplasms - surgery (7) 7
adrenocortical carcinoma - drug therapy (7) 7
carcinoma (7) 7
medicine & public health (7) 7
mitotane (7) 7
neoplasm staging (7) 7
registries (7) 7
adrenal cortex neoplasms - blood (6) 6
adrenal cortex neoplasms - pathology (6) 6
antineoplastic agents, hormonal - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
comorbidity (6) 6
disease (6) 6
follow-up studies (6) 6
netherlands (6) 6
oncology, experimental (6) 6
survival rate (6) 6
tumors (6) 6
adrenal cortex neoplasms - diagnosis (5) 5
adrenal-cortical carcinoma (5) 5
adrenocortical carcinoma - blood (5) 5
antineoplastic agents, hormonal - pharmacokinetics (5) 5
care and treatment (5) 5
cohort studies (5) 5
diagnosis (5) 5
hypoglycemic agents - therapeutic use (5) 5
infant (5) 5
mitotane - administration & dosage (5) 5
mitotane - adverse effects (5) 5
mitotane - blood (5) 5
mitotane - pharmacokinetics (5) 5
prevalence (5) 5
thyroid neoplasms - mortality (5) 5
adrenal cortex neoplasms - metabolism (4) 4
adrenocortical carcinoma - diagnosis (4) 4
adrenocortical carcinoma - surgery (4) 4
article (4) 4
carcinoma - mortality (4) 4
child, preschool (4) 4
co-morbidity (4) 4
cohort (4) 4
colorectal neoplasms - mortality (4) 4
dose-response relationship, drug (4) 4
drug therapy (4) 4
human physiology (4) 4
mellitus (4) 4
metabolic diseases (4) 4
microbiology (4) 4
nursing (4) 4
o,p'ddd (4) 4
quality of life (4) 4
surveys and questionnaires (4) 4
survivors - psychology (4) 4
thyroid cancer (4) 4
thyroid neoplasms - psychology (4) 4
thyroid neoplasms - therapy (4) 4
time factors (4) 4
treatment (4) 4
treatment outcome (4) 4
united-states (4) 4
acquired immunodeficiency syndrome (3) 3
adherence (3) 3
adrenal cortex - pathology (3) 3
adrenal cortex neoplasms - mortality (3) 3
adrenal gland neoplasms - genetics (3) 3
adrenalectomy (3) 3
adrenocortical carcinoma - mortality (3) 3
adrenocortical carcinoma - pathology (3) 3
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (3) 3
Robarts - Stacks (3) 3
Art - Oversize (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - May be requested in 6-10 wks (1) 1
Credit Valley Hospital - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
by Berruti, A and Baudin, E and Gelderblom, H and Haak, H.R and Porpiglia, F and Fassnacht, M and Pentheroudakis, G and ESMO Guidelines Working Grp and ESMO Guidelines Working Group and on behalf of the ESMO Guidelines Working Group
Annals of Oncology, ISSN 0923-7534, 10/2012, Volume 23, Issue 7, pp. vii131 - vii138
MITOTANE | MANAGEMENT | PHEOCHROMOCYTOMA | ONCOLOGY | RECOMMENDATIONS | PREDICTORS | ADRENOCORTICAL CARCINOMA | PHASE-II | CLASSIFICATION | PROGNOSTIC VALUE | EXPRESSION | Neoplasms, Hormone-Dependent - diagnosis | Risk Assessment | Pheochromocytoma - diagnosis | Adrenocortical Carcinoma - secondary | Humans | Adrenocortical Carcinoma - diagnosis | Chemoradiotherapy, Adjuvant | Adrenocortical Carcinoma - therapy | Mitotane - therapeutic use | Adrenal Gland Neoplasms - diagnosis | Adrenalectomy | Neoplasms, Hormone-Dependent - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Hormone-Dependent - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Pheochromocytoma - secondary | Neoplasm Staging | Pheochromocytoma - therapy | Adrenal Gland Neoplasms - pathology | Adrenal Gland Neoplasms - therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection
by Beuschlein, Felix and Weigel, Jens and Saeger, Wolfgang and Kroiss, Matthias and Wild, Vanessa and Daffara, Fulvia and Libé, Rosella and Ardito, Arianna and Al Ghuzlan, Abir and Quinkler, Marcus and Oßwald, Andrea and Ronchi, Cristina L and de Krijger, Ronald and Feelders, Richard A and Waldmann, Jens and Willenberg, Holger S and Deutschbein, Timo and Stell, Anthony and Reincke, Martin and Papotti, Mauro and Baudin, Eric and Tissier, Frédérique and Haak, Harm R and Loli, Paola and Terzolo, Massimo and Allolio, Bruno and Müller, Hans-Helge and Fassnacht, Martin
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 03/2015, Volume 100, Issue 3, pp. 841 - 849
Background: Recurrence of adrenocortical carcinoma (ACC) even after complete (R0) resection occurs frequently. Objective: The aim of this study was to identify... 
SURVIVAL | DIAGNOSIS | MITOTANE | MANAGEMENT | EFFICACY | OPEN ADRENALECTOMY | ENDOCRINOLOGY & METABOLISM | RECURRENCE | ADJUVANT RADIOTHERAPY | CANCER | TUMORS | Predictive Value of Tests | Prognosis | Adrenocortical Carcinoma - surgery | Humans | Middle Aged | Adrenocortical Carcinoma - diagnosis | Child, Preschool | Infant | Ki-67 Antigen - metabolism | Male | Young Adult | Adrenal Cortex Neoplasms - diagnosis | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Adrenocortical Carcinoma - mortality | Child | Adrenal Cortex Neoplasms - mortality | Adrenal Cortex Neoplasms - surgery | Treatment Outcome | Adrenalectomy | Adolescent | Survival Analysis | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Comparison of Two Mitotane Starting Dose Regimens in Patients With Advanced Adrenocortical Carcinoma
by Kerkhofs, T. M and Baudin, E and Terzolo, M and Allolio, B and Chadarevian, R and Mueller, H. H and Skogseid, B and Leboulleux, S and Mantero, F and Haak, H. R and Fassnacht, M
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 12/2013, Volume 98, Issue 12, pp. 4759 - 4767
Context: Mitotane is the only approved drug for treatment of adrenocortical carcinoma. Its pharmacokinetic properties are not fully elucidated and different... 
METABOLITES | THERAPY | PLASMA | PHARMACOLOGY | O,P'-DDD | ENDOCRINOLOGY & METABOLISM | MONITORED MITOTANE | O,P'DDD | CYP3A4 | CANCER | CLINICAL MANAGEMENT | Dichlorodiphenyl Dichloroethylene - blood | Adrenal Cortex Neoplasms - blood | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Gastrointestinal Diseases - physiopathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Adrenal Cortex - pathology | Antineoplastic Agents, Hormonal - pharmacokinetics | Dose-Response Relationship, Drug | Adrenocortical Carcinoma - pathology | Antineoplastic Agents, Hormonal - adverse effects | Adrenocortical Carcinoma - drug therapy | Drug Interactions | Antineoplastic Agents, Hormonal - therapeutic use | Biotransformation | Adult | Female | Adrenal Cortex - drug effects | Mitotane - administration & dosage | Severity of Illness Index | Adrenocortical Carcinoma - secondary | Antineoplastic Agents, Hormonal - administration & dosage | Mitotane - adverse effects | Adrenal Cortex Neoplasms - pathology | Mitotane - therapeutic use | Mitotane - pharmacokinetics | Adrenal Cortex Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neurotoxicity Syndromes - physiopathology | Adrenocortical Carcinoma - blood | Drug Monitoring | Neoplasm Staging | Gastrointestinal Diseases - chemically induced | Phenylacetates - blood
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Organisational Factors Induce Prolonged Emergency Department Length of Stay in Elderly Patients- A Retrospective Cohort Study
by Brouns, S.H.A and Stassen, P.M and Lambooij, S.L.E and Dieleman, J and Vanderfeesten, I.T.P and Haak, H.R
PLoS One, ISSN 1932-6203, 01/2015, Volume 10, Issue 8
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: Potential mechanisms: Reply to Pouwer F (letter)
by Zanders, M.M.J and Haak, H.R and Sukel, M.P and van de Poll-Franse, L.V and Johnson, J.A
Diabetologia, ISSN 0012-186X, 2015, Volume 58, Issue 6, pp. 1380 - 1381
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection
by Terzolo, M and Baudin, A. E and Ardito, A and Kroiss, M and Leboulleux, S and Daffara, F and Perotti, P and Feelders, R. A and DeVries, J. H and Zaggia, B and de Francia, S and Volante, M and Haak, H. R and Allolio, B and Al Ghuzlan, A and Fassnacht, M and Berruti, A
European journal of endocrinology / European Federation of Endocrine Societies, ISSN 0804-4643, 2013, Volume 169, Issue 3, pp. 263 - 270
Mitotane plasma concentrations ≥ 14 mg/l have been shown to predict tumor response and better survival in patients with advanced adrenocortical carcinoma... 
CONTROVERSY | SERIES | MANAGEMENT | THERAPY | LONG-TERM SURVIVAL | ENDOCRINOLOGY & METABOLISM | ADRENAL CANCER | UPDATE | O,P'DDD | Adrenal Cortex Neoplasms - blood | Follow-Up Studies | Adrenocortical Carcinoma - surgery | Humans | Middle Aged | Male | Adrenal Cortex - pathology | Antineoplastic Agents, Hormonal - pharmacokinetics | Young Adult | Antineoplastic Agents, Hormonal - adverse effects | Adrenocortical Carcinoma - drug therapy | Antineoplastic Agents, Hormonal - therapeutic use | Adult | Female | Retrospective Studies | Adrenal Cortex - drug effects | Chemotherapy, Adjuvant | Adrenal Cortex Neoplasms - prevention & control | Neoplasm Recurrence, Local - prevention & control | Adrenal Cortex Neoplasms - surgery | Mitotane - adverse effects | Adrenocortical Carcinoma - prevention & control | Mitotane - therapeutic use | Adrenal Cortex - surgery | Mitotane - pharmacokinetics | Antineoplastic Agents, Hormonal - blood | Adrenal Cortex Neoplasms - drug therapy | Mitotane - blood | Adolescent | Survival Analysis | Aged | Adrenocortical Carcinoma - blood | Drug Monitoring | Neoplasm Staging | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: Results from a large population-based follow-up study
by Ruiter, Rikje and Visser, Loes and Coebergh, Jan Willem and Herk-Sukel, Myrthe and Haak, H.R and Geelhoed-Duijvestijn, P.H and Straus, Sabine and Herings, Ron and Stricker, Bruno
Diabetologia: clinical and experimental diabetes and metabolism, ISSN 0012-186X, 01/2012, Volume 55, Issue 1, pp. 51 - 62
textabstractAims/hypothesis Several publications suggest an association between certain types of insulin and cancer, but with conflicting results. We... 
Insulin glargine | Medicine & Public Health | Human Physiology | Metabolic Diseases | Insulin analogues | Internal Medicine | Breast cancer | Insulin | Cancer | MORTALITY | METAANALYSIS | DIABETES-MELLITUS | BREAST-CANCER | THERAPY | RESEARCH NETWORK | COLORECTAL-CANCER | ENDOCRINOLOGY & METABOLISM | MALIGNANCIES | COHORT | EXPOSURE | Follow-Up Studies | Humans | Middle Aged | Netherlands - epidemiology | Patient Admission | Male | Risk | Incidence | Dose-Response Relationship, Drug | Neoplasms - complications | Neoplasms - chemically induced | Hypoglycemic Agents - administration & dosage | Community Pharmacy Services | Female | Insulin - analogs & derivatives | Medical Record Linkage | Diabetes Mellitus, Type 2 - complications | Breast Neoplasms - epidemiology | Hypoglycemic Agents - therapeutic use | Proportional Hazards Models | Insulin, Regular, Human - adverse effects | Insulin - administration & dosage | Insulin, Regular, Human - therapeutic use | Insulin, Regular, Human - administration & dosage | Breast Neoplasms - complications | Insulin, Long-Acting - adverse effects | Insulin, Long-Acting - administration & dosage | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Breast Neoplasms - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Electronic Health Records | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Insulin - therapeutic use | Neoplasms - epidemiology | Cohort Studies | Heterocyclic compounds | Oncology, Experimental | Research | Risk factors | Public health | Medical informatics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Abstracts from ATTD 20158th International Conference on Advanced Technologies & Treatments for DiabetesParis, France—February 18–21, 2015
by Reznik, Y and Reznik, Y and Pender, J and Spaniolas, K and Stefan, D and Wohlgemuth, S and Mozer, A and Sippey, M and Hounshell, K and Wilinska, M.E and Hovorka, R and Hovorka, R and Hovorka, R and Hovorka, R and Haluzik, M and Loebker, W and Chase, H.P and Maahs, D and Wadwa, P and Buckingham, B and Wilson, D and Ly, T and Lum, J and Calhoun, P and Raghinaru, D and Cameron, F and Bequette, B.W and Hramiak, I and Beck, R and Remus, K and Blaesig, S and Biester, T and Fath, M and Lange, K and Kordonouri, O and Haahr, H and Jensen, L and Erichsen, L and Hompesch, M and Cobelli, C and Cobelli, C and Gibney, M and Swinney, M and Xue, Z and Mendes, G.F and Miranda, F and Batista, L.F and Lins, T.C and Colberg, S.R and Dall, M and Parkin, C and Warner, J and Rabbone, I and Minuto, N and Scaramuzza, A and Bonfanti, R and Schiaffini, R and Toni, S and Iafusco, D and Lombardo, F and Pistorio, A and Pistorio, A and De Portu, S and Cohen, O and Cohen, O and Conget, I and Conget, I and Racault, A.S and Shin, J and Runzis, S and Reznik, Y and Petitti, A and Ferrari, M and Radaelli, S and Comaschi, V and Zuccotti, G.V and Ambrosino, J and Walders-Abramson, N and Ly, T and Maahs, D and Maahs, D and Weinzimer, S and Weinzimer, S and Buckingham, B and Buckingham, B and Buckingham, B and Melmer, A and Mader, J and Schütz-Fuhrmann, I and Rose-Engels, H and Götz, G and Pfeiffer, M and Hermann, J and Stettler, C and Holl, R and Mader, J.K and Aberer, F and Poettler, T and Trautmann, M and Pieber, T and ...
Diabetes Technology & Therapeutics, ISSN 1520-9156, 02/2015, Volume 17, Issue S1, pp. A-1 - A-180
Abstracts
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Fatigue Among Short- and Long-Term Thyroid Cancer Survivors: Results from the Population-Based PROFILES Registry
by Husson, Olga and Nieuwlaat, Willy-Anne and Oranje, Wilma A and Haak, Harm R and van de Poll-Franse, Lonneke V and Mols, Floortje
Thyroid, ISSN 1050-7256, 10/2013, Volume 23, Issue 10, pp. 1247 - 1255
Background: The aims of this study were (i) to obtain insight into the prevalence of fatigue among short- and long-term thyroid cancer (TC) survivors, by... 
Thyroid Cancer and Nodules | UNITED-STATES | SARCOIDOSIS PATIENTS | PRACTICE GUIDELINES | ENDOCRINOLOGY & METABOLISM | TESTICULAR CANCER | INITIAL TREATMENT | HOSPITAL ANXIETY | QUALITY-OF-LIFE | RANDOMIZED CONTROLLED-TRIAL | ASSESSMENT SCALE | PSYCHOMETRIC QUALITIES | Depression - physiopathology | Prevalence | Thyroid Neoplasms - psychology | Humans | Middle Aged | Netherlands - epidemiology | Cost of Illness | Fatigue - etiology | Male | Neuromuscular Diseases - physiopathology | Depression - etiology | Thyroid Neoplasms - therapy | Cognition Disorders - etiology | Stress, Psychological - epidemiology | Anxiety - epidemiology | Adult | Female | Registries | Survivors - psychology | Severity of Illness Index | Cognition Disorders - physiopathology | Depression - epidemiology | Cross-Sectional Studies | Anxiety - physiopathology | Combined Modality Therapy - adverse effects | Thyroid Neoplasms - physiopathology | Fatigue - epidemiology | Fatigue - physiopathology | Quality of Life | Aged | Neuromuscular Diseases - etiology | Neuromuscular Diseases - epidemiology | Cognition Disorders - epidemiology | Anxiety - etiology | Stress, Psychological - etiology | Cohort Studies | Stress, Psychological - physiopathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Health-related quality of life among thyroid cancer survivors: A systematic review
by Husson, O and Haak, H.R and Oranje, W.A and Mols, F and Reemst, P.H.M and van de Poll-Franse, L.V
Clinical Endocrinology, ISSN 0300-0664, 2011, Volume 75, Issue 4, pp. 544 - 554
Background  Treatment and follow‐up care procedures of thyroid cancer impose great challenges on survivors and could potentially affect their health‐related... 
RECOMBINANT HUMAN THYROTROPIN | SHORT-TERM HYPOTHYROIDISM | CARCINOMA PATIENTS | DEPRESSION | THERAPY | 3-WEEK THYROXINE WITHDRAWAL | ENDOCRINOLOGY & METABOLISM | CONSEQUENCES | HORMONE WITHDRAWAL | ABLATION | REMNANT | Thyroid Neoplasms - physiopathology | Thyroid Neoplasms - therapy | Thyroid Neoplasms - drug therapy | Humans | Quality of Life | Female | Male | Cancer survivors | Care and treatment | Ablation (Surgery) | Thyroid cancer | Oncology, Experimental | Glycoproteins | Research | Hormones | Cancer | Quality of life
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Developing treatment for adrenocortical carcinoma
by Kerkhofs, T.M.A and Ettaieb, M.H.T and Hermsen, I.G.C and Haak, H.R
Endocrine-Related Cancer, ISSN 1351-0088, 01/2015, Volume 22, Issue 6, pp. R325 - R338
Cancer of the adrenal cortex (ACC) is a rare endocrine malignancy with limited treatment options. Patients typically present with autonomous hormonal... 
Carcinoma | Adrenal cortex | Adrenal hormone | MITOTANE TREATMENT | LONG-TERM SURVIVAL | PHASE-II | adrenal cortex | CLINICAL MANAGEMENT | LAPAROSCOPIC ADRENALECTOMY | CANCER-PATIENTS | LOCAL RECURRENCE | ONCOLOGY | carcinoma | ENDOCRINOLOGY & METABOLISM | adrenal hormone | ADJUVANT RADIOTHERAPY | SURGICAL RESECTION | ADRENAL-CORTICAL CARCINOMA | Recurrence | Adrenal Cortex Neoplasms - epidemiology | Prognosis | Genes, Neoplasm | Humans | Symptom Assessment | Gene Expression Profiling | Molecular Targeted Therapy | RNA, Neoplasm - blood | Antineoplastic Agents, Hormonal - pharmacokinetics | Adrenal Cortex Neoplasms - diagnosis | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Metastasis | Multicenter Studies as Topic | Antineoplastic Agents, Hormonal - therapeutic use | Carcinoma - epidemiology | Immunotherapy | Carcinoma - pathology | Radiotherapy, Adjuvant | Mitotane - adverse effects | Carcinoma - diagnosis | Survival Rate | Clinical Trials as Topic | Combined Modality Therapy | Adrenal Cortex Neoplasms - pathology | Cancer Care Facilities | Forecasting | Mitotane - therapeutic use | Mitotane - pharmacokinetics | Adrenal Cortex Neoplasms - genetics | Adrenal Cortex Neoplasms - therapy | Adrenalectomy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma - genetics | Carcinoma - therapy | MicroRNAs - blood | Drug Monitoring | Glucocorticoids - biosynthesis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text The impairment in daily life of obese haemophiliacs
by Biere-Rafi, S and Haak, B. W and Peters, M and Gerdes, V. E. A and Büller, H. R and Kamphuisen, P. W
Haemophilia, ISSN 1351-8216, 2011, Volume 17, Issue 2, pp. 204 - 208
Obesity is a major health concern not only in the general population but also in patients with haemophilia. Little is known about the consequences of obesity... 
haemophilia | haemophilia activities list | factor VIII concentrate | impairments | bleeds | obesity | Bleeds | Obesity | Haemophilia | Impairments | Factor VIII concentrate | Haemophilia activities list | ADULTS | STATE | PREVALENCE | HEMATOLOGY | ACTIVITIES LIST | Disability Evaluation | Hemorrhage - epidemiology | Obesity - complications | Humans | Middle Aged | Risk Factors | Hemophilia A - complications | Activities of Daily Living | Young Adult | Osteoarthritis - epidemiology | Hemorrhage - etiology | Adult | Surveys and Questionnaires | Aged | Hemophilia A - drug therapy | Osteoarthritis - etiology | Factor VIII - therapeutic use | Medical colleges | Blood coagulation factor VIII | Osteoarthritis | Risk factors | Hemophilia | Activities | Physicians | Preventive health | Joints | Patients | Weight
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial
by Alam, Nadia and Alam, N and Oskam, E and Oskam, Erick and Stassen, P.M and Stassen, Patricia M and Exter, Pieternel van and van de Ven, P.M and van de Ven, Peter M and Haak, Harm R and Haak, H.R and Holleman, F and Holleman, Frits and Zanten, Arthur van and Leeuwen-Nguyen, Hien van and Bon, V and Bon, Victor and Duineveld, B.A.M and Duineveld, Bart A M and Nannan Panday, R.S and Nannan Panday, Rishi S and Kramer, M.H.H and Kramer, Mark H H and Nanayakkara, Prabath W B and Nanayakkara, P.W.B and van Exter, P and Goselink, J and De Kreek, A and van Grunsven, P and Biekart, M and Deddens, G.J and Weijschede, F and Rijntjes, N and Franschman, G and Janssen, J and Frenken, J and Versluis, J and Boomars, R and de Vries, G and den Boer, E and van Gent, A and Willeboer, M and Buunk, G and Timmers, G.J and Snijders, F and Posthuma, N and Stoffelen, S and Claassens, S and Ammerlaan, H and Sankatsing, S and Alsma, J and van Zanten, A and Slobbe, L and de Melo, M.M and Dees, A and Carels, G and Wabbijn, M and van Leeuwen-Nguyen, T.T.H and Assink, J and van der Honing, A and Luik, P and Poortvliet, W and Schouten, W.E.M and Veenstra, J and Holkenborg, J and Cheung, T.C and van Bokhorst, J and Kors, B and Louis- Wattel, G.H and Roeleveld, T and Toorians, A and Jellema, W and Govers, A and Kaasjager, H.A.H and Dekker, D and Verhoeven, M.A.M and Flietstra, T and Roest, L and Peters, E.J.G and Hekker, T.A.M and Ang, W and van der Wekken, W and Ghaem Maghami, P and Kanen, B and Wesselius, H and Heesterman, L and Zwietering, A.N and Stoffers, J and PHANTASI Trial Investigators and ORCA Onderzoeks Consortium Acute and PHANTASi Trial Investigators and the ORCA (Onderzoeks Consortium Acute Geneeskunde) Research Consortium the Netherlands
The Lancet Respiratory Medicine, ISSN 2213-2600, 01/2018, Volume 6, Issue 1, pp. 40 - 50
Emergency medical services (EMS) personnel have already made substantial contributions to improving care for patients with time-dependent illnesses, such as... 
UNITED-STATES | MORTALITY | DEFINITIONS | GOAL-DIRECTED THERAPY | IMPACT | EMERGENCY MEDICAL-SERVICES | RESPIRATORY SYSTEM | SEPTIC SHOCK | EARLY WARNING SCORE | TIME | EPIDEMIOLOGY | CRITICAL CARE MEDICINE | Sepsis - drug therapy | Netherlands | Humans | Aged, 80 and over | Female | Male | Treatment Outcome | Aged | Emergency Medical Services - methods | Ambulances | Anti-Bacterial Agents - administration & dosage | Complications and side effects | Sepsis | Dosage and administration | Research | Antibiotics | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Unplanned readmissions among patients presenting with nonspecific complaints
by Wachelder, J.J.H and van Galen, L.S and Kellett, J and Nickel, C.H and Haak, H.R and Safer Home Consortium and safer@home consortium
European Journal of Internal Medicine, ISSN 0953-6205, 08/2018, Volume 54, pp. e36 - e37
Emergency department | Non-specific complaints | Emergency medicine | Readmissions | MEDICINE, GENERAL & INTERNAL | HOSPITAL READMISSION | EMERGENCY-DEPARTMENT | Prospective Studies | Europe | Humans | Middle Aged | Aged, 80 and over | Female | Male | Aged | Emergency Service, Hospital - statistics & numerical data | Patient Readmission - statistics & numerical data
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes
by Zanders, M.M.J and Haak, H.R and van Herk-Sukel, M.P.P and van de Poll-Franse, L.V and Johnson, J.A
Diabetologia, ISSN 0012-186X, 01/2015, Volume 58, Issue 5, pp. 951 - 960
Adherence to glucose-lowering drug (GLD) treatment regimens is crucial for metabolic control and improving prognosis. Because a diagnosis of cancer might have... 
Adherence | Glucose-lowering drugs | Medicine & Public Health | Human Physiology | Metabolic Diseases | Internal Medicine | Cancer | MORTALITY | ADMINISTRATIVE CLAIMS DATA | POPULATION | METFORMIN | GLYCEMIC CONTROL | ENDOCRINOLOGY & METABOLISM | MELLITUS | MEDICATION ADHERENCE | Hypoglycemic Agents - therapeutic use | Diabetes Mellitus, Type 2 - psychology | Medication Adherence - psychology | Humans | Middle Aged | Male | Neoplasms - diagnosis | Neoplasms - psychology | Adult | Female | Aged | Retrospective Studies | Diabetes Mellitus, Type 2 - drug therapy | Analysis | Diabetes | Glucose | Drug therapy | Patient compliance | Dextrose | Diabetes therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights